Michael Geissler

Gemcitabine plus sorafenib versus gemcitabine alone in advanced biliary tract cancer: a double-blind placebo-controlled multicentre phase II AIO study with biomarker and serum programme.

F. Lammert, P. Galle, F. Kolligs, 2014, European journal of cancer.

Multicentre phase II trial of trastuzumab and capecitabine in patients with HER2 overexpressing metastatic pancreatic cancer

C. Schmoor, V. Heinemann, R. Hofheinz, 2012, British Journal of Cancer.

Outpatient chemotherapy with gemcitabine and oxaliplatin in patients with biliary tract cancer

O. Opitz, B. Riecken, H. Henß, 2006, British Journal of Cancer.